Pharmacogenetic analysis of SNPs in genes involved in the pharmacokinetics and response to lopinavir/ritonavir therapy
López Aspiroz, E, Cabrera Figueroa, S E, Porras Hurtado, G L, Cruz Guerrero, R, Domínguez-Gil Hurlé, A, Carracedo, A
Published in Current drug metabolism (01.09.2013)
Published in Current drug metabolism (01.09.2013)
Get more information
Journal Article
4CPS-146 Effectiveness and safety of omalizumab in the treatment of severe uncontrolled asthma
Portillo Horcajada, L, Garcia Yubero, C, Garcia De Santiago, B, Lopez Aspiroz, E, Garcia Martin, E, Larrubia Marfil, Y, Barro Ordovas, JP, Llorente Gutierrez, J, Martinez Hernandez, A
Published in European journal of hospital pharmacy. Science and practice (01.03.2020)
Published in European journal of hospital pharmacy. Science and practice (01.03.2020)
Get full text
Journal Article
4CPS-167 Current trends in the use of check-point inhibitors for non-small-cell lung cancer
Alvarez-Yuste, A, Perez-Abanades, M, Gallego-Aranda, T, Lopez-Aspiroz, E, Ibañez-Zurriaga, A, Garcia-Peralo, A, Escudero-Sanchez, G, Duque-Tebar, P, Morell-Baladron, A
Published in European journal of hospital pharmacy. Science and practice (23.03.2023)
Published in European journal of hospital pharmacy. Science and practice (23.03.2023)
Get full text
Journal Article
Nuevas estrategias en la optimización posológica de lopinavir/ritonavir en pacientes infectados por el virus de la inmunodeficiencia humana
López Aspiroz, Elena, Cabrera Figueroa, Salvador Enrique, Domínguez-Gil Hurlé, Alfonso, García Sánchez, María José
Published in Enfermedades infecciosas y microbiología clínica (2013)
Published in Enfermedades infecciosas y microbiología clínica (2013)
Get full text
Journal Article